Noveratech, LLC

LOUISVILLE, KY 40202

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $2.94MM
First Award Date 04/19/12
Most Recent Award Date 09/01/17

Key Personnel

Last Name Name Awards Contact
Chien Sufan Chien 9 Message

9 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/01/17 - 08/31/18

ABSTRACT Diabetes is the leading cause of nontraumatic lower extremity amputations in the United States. Diabetic foot ulcers (DFUs) are responsible for more hospitalizations than any other diabetic complications. Currently, even the best available treatments achieve only a 50% healing rate for these wounds?and this healing is often only tempor...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/07/16 - 08/31/17

ABSTRACT Diabetes is the leading cause of nontraumatic lower extremity amputations in the United States. Diabetic foot ulcers (DFUs) are responsible for more hospitalizations than any other diabetic complications. Currently, even the best available treatments achieve only a 50% healing rate for these wounds?and this healing is often only tempor...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/06/16 - 08/31/17

ABSTRACT Diabetes is the leading cause of nontraumatic lower extremity amputations in the United States. Diabetic foot ulcers (DFUs) are responsible for more hospitalizations than any other diabetic complications. Currently, even the best available treatments achieve only a 50% healing rate for these wounds?and this healing is often only tempor...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 08/01/15 - 01/31/16

DESCRIPTION (provided by applicant): This proposal is in response to the mission of the Office of Research Infrastructure Programs (ORIP) to "Develop and provide access to critical animal models that offer essential clues to a broad range of human disorders". Our goal is to develop a universal animal model that best recapitulates non-healing hum...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-058
Budget: 04/01/15 - 09/30/15

DESCRIPTION (provided by applicant): This proposal is submitted in response to the new NIDDK announcement (PA-14- 058) calling for development of new diagnostic, monitoring, and therapeutics technologies for the complications of type 1 diabetes (T1D). An estimated 15-25% of the 25.8 million diabetic patients in this country will develop diabetic...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-058
Budget: 02/09/15 - 08/08/15

DESCRIPTION (provided by applicant): This proposal is submitted in response to the new NIDDK announcement (PA-14- 058) calling for development of methodologies or biomarkers to help understand the pathophysiology of T1D type 1 diabetes (T1D) complications. An estimated 15-25% of the 25.8 million diabetic patients in this country will develop dia...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/25/13 - 03/24/14

DESCRIPTION (provided by applicant): The specific aim of this phase I proposal is to test our newly developed intracellular ATP delivery technique for abdominal wound dehiscence. More than 200,000 incisional hernia repairs are performed annually in the United States at a financial cost of nearly 2.5 billion dollars without considering the loss o...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/01/13 - 03/31/14

DESCRIPTION (provided by applicant): The specific aims of this proposal are to use a newly developed intracellular energy delivery technique to enhance resuscitation, and to study the relationship between tissue high-energy phosphate supplementation and tissue necrosis and apoptosis during hemorrhagic shock. In most western countries, trauma/he...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/19/12 - 03/31/13

DESCRIPTION (provided by applicant): The specific aims of this proposal are to use a newly developed intracellular energy delivery technique to enhance resuscitation, and to study the relationship between tissue high-energy phosphate supplementation and tissue necrosis and apoptosis during hemorrhagic shock. In most western countries, trauma/he...